Related Experiment Videos
[Limitations of meta-analysis from published data in epidemiological research]
M Blettner1, B Schlehofer, W Sauerbrei
1Abteilung Epidemiologie, Deutsches Krebsforschungszentrum, Heidelberg.
Sozial- Und Praventivmedizin
|January 1, 1997
Summary
Meta-analyses of published epidemiological data can be unreliable for assessing risk factors. This review questions the feasibility of dose-response analyses and pooled risk estimates from such studies.
Area of Science:
- Epidemiology
- Biostatistics
Background:
- Meta-analyses of epidemiological studies are increasingly common for evaluating risk factors with inconsistent findings across studies.
- These meta-analyses often rely on published data, raising questions about data reliability and analytical capabilities.
Purpose of the Study:
- To critically evaluate meta-analyses conducted using published epidemiological data.
- To determine the feasibility of performing qualitative and quantitative dose-response analyses.
- To assess the validity of arguments for meta-analysis in observational studies compared to clinical trials.
Main Methods:
- Discussion of meta-analysis methodologies for published versus experimental/clinical trial data.
- Comparative analysis of meta-analysis justifications in clinical trials and observational studies.
- Examination of challenges in estimating a single pooled risk estimate from published data.
- Illustrative examples from literature to highlight issues with published data meta-analyses.
Main Results:
- Significant challenges exist in obtaining reliable information from meta-analyses of published epidemiological data.
- Performing qualitative and quantitative dose-response analyses may not be consistently achievable.
- Arguments supporting meta-analysis in clinical trials may not directly translate to observational studies.
- Estimating a single, reliable pooled risk estimate presents considerable difficulties.
Conclusions:
- Caution is advised when interpreting meta-analyses based solely on published epidemiological data.
- The reliability of dose-response and pooled risk estimates requires careful scrutiny.
- Further methodological development is needed for robust meta-analyses of observational studies.